Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,308,298
-$80,657 QoQ
Shares Held
8,348
-8.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#548
of 1,606 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. NVS ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
This page
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,308,298 | 8,348 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,388,955 | 9,093 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,272,126 | 9,227 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,239,183 | 9,663 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,228,614 | 10,153 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,159,614 | 10,402 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,010,856 | 10,388 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,200,003 | 10,433 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,189,477 | 11,173 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $1,085,310 | 11,220 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,142,980 | 11,320 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,172,612 | 11,512 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,219,497 | 12,085 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,096,272 | 11,916 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,123,295 | 12,382 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $959,170 | 12,619 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,079,025 | 12,765 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,202,789 | 13,707 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,163,176 | 13,298 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $970,892 | 11,872 | Shares | Sole | 2021-11-04 | |
| 2021-03-31 | $1,026,016 | 12,003 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,170,648 | 12,397 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,026,562 | 11,805 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $992,706 | 11,366 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,167,079 | 14,155 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||